On September 24, 2023, it was reported that &My Legacy Advisors LLC, a financial advisory firm, has acquired a new position in The Sherwin-Williams Company (NYSE:SHW). According to the company’s most recent Form 13F filing with the Securities and Exchange Commission (SEC), &My Legacy Advisors LLC purchased 802 shares of the specialty chemicals company’s stock during the second quarter. The value of this acquisition is estimated to be approximately $214,000.
The Sherwin-Williams Company is a renowned name in the specialty chemicals industry. As per our latest analysis on Sherwin-Williams, it is evident that the company continues to make strides in its performance.
In addition to this acquisition news, The Sherwin-Williams Company recently announced its quarterly dividend payment. This dividend was paid on September 8th to stockholders of record as of August 18th. The dividend amount was $0.605 per share. It should be noted that investors needed to own shares by August 17th, which was the ex-dividend date, in order to receive this payout.
At an annualized basis, the dividend comes out to be $2.42 per share, resulting in a dividend yield of 0.95%. It should be mentioned that Sherwin-Williams has a payout ratio of 26.86% at present.
This news reinforces Sherwin-Williams’ commitment towards rewarding its shareholders through regular dividends. These dividends not only provide investors with a steady income stream but also reflect the company’s financial stability and confidence in its future prospects.
Overall, &My Legacy Advisors LLC’s recent acquisition of shares in The Sherwin-Williams Company showcases their confidence and belief in the company’s growth potential. It will be interesting to see how this investment contributes towards both parties’ long-term objectives and success within the specialty chemicals industry.
Interested readers can further explore our comprehensive analysis on Sherwin-Williams to gain a deeper understanding of the company’s performance, financial standing, and future prospects.
[bs_slider_forecast ticker=”DUK”]
Institutional Investors Show Strong Interest in Sherwin-Williams Stock Amidst Positive Analyst Ratings and Steady Financial Growth
Institutional investors seem to be making significant adjustments to their holdings of Sherwin-Williams (NYSE:SHW) stock. According to recent reports, several firms have modified their positions in the specialty chemicals company.
HHM Wealth Advisors LLC, for instance, witnessed a staggering increase of 1,716.7% in its holdings of Sherwin-Williams stock during the first quarter. This rise translated to the firm now owning 109 shares of the company’s stock, which is valued at $25,000 after acquiring an additional 103 shares in the previous quarter.
Similarly, TCI Wealth Advisors Inc. also experienced a substantial increase in its stake in Sherwin-Williams by 296.9%. The firm now possesses 127 shares worth $29,000 after purchasing an additional 95 shares last quarter.
Householder Group Estate & Retirement Specialist LLC joined the bandwagon by buying a new stake worth approximately $36,000 during the first quarter.
Colonial Trust Co SC followed suit with a significant growth of 315.9% in its ownership of Sherwin-Williams stock. The firm’s current position stands at 183 shares worth $41,000 after obtaining an additional 139 shares in the last quarter.
Finally, Gradient Investments LLC decided to jump on board as well with a remarkable increase of 156.2%. The firm now owns 187 shares valued at $42,000 following the acquisition of an extra 114 shares during the first quarter.
The cumulative impact of these institutional moves should not be underestimated as they collectively represent a considerable portion of ownership within Sherwin-Williams. In fact, institutional investors and hedge funds currently account for about 75.87% of the company’s total stockholding.
Besides attracting institutional attention due to some major adjustments made by investors over time, Sherwin-Williams has also garnered interest from equities research analysts who have weighed in on the company recently.
Citigroup, for instance, raised its price objective on Sherwin-Williams from $310.00 to $320.00 and provided the stock with a “buy” rating in a research note issued on July 27th. Similarly, other firms such as 58.com, Royal Bank of Canada, and StockNews.com have expressed positive sentiments about the company’s prospects by either restating or raising their ratings and target prices.
BMO Capital Markets also got in on the action by increasing its price objective from $275.00 to $300.00 and providing an “outperform” rating. In total, five analysts have given the stock a hold rating, while fifteen analysts have assigned a buy rating to Sherwin-Williams.
Amidst all this attention and speculation surrounding Sherwin-Williams’ performance and potential growth trajectory, shares of NYSE:SHW opened at $254.67 on Friday. Over the past year, the company’s stock has traded between a low of $195.24 and a high of $283.80.
From a technical perspective, Sherwin-Williams displays fluctuating figures in key indicators such as fifty-day moving average price ($270.33) and two-hundred-day moving average price ($246.81). The firm maintains a current ratio of 1.00, indicating its ability to cover short-term obligations efficiently; meanwhile, its quick ratio stands at 0.62.
Additionally, Sherwin-Williams showcases sound financials with a debt-to-equity ratio of 2.50 alongside a market capitalization of an impressive $65.49 billion.
In terms of recent financial performance, Sherwin-Williams posted its quarterly earnings results on Tuesday, July 25th. The specialty chemicals company exceeded analysts’ consensus estimates by reporting earnings per share (EPS) of $3.29 instead of the estimated $2.71 EPS for the quarter.
The strong performance could be attributed to a net margin of 10.20% and a remarkable return on equity of 83.63%. Moreover, the company’s revenue for the quarter reached $6.24 billion, surpassing estimates of $6.03 billion.
When compared to the same quarter last year, Sherwin-Williams achieved a growth rate of 6.3% in quarterly revenue, bolstering investor confidence in its ability to continue its upward trajectory.
Given these positive figures and recent developments, analysts anticipate that The Sherwin-Williams Company will maintain steady growth and post an EPS of approximately 9.78 for the current fiscal year.
In conclusion, Sherwin-Williams’ impressive performance, with both institutional investors making significant adjustments to their holdings and favorable ratings from equities research analysts, reinforces the company’s position as a viable investment opportunity. With steady financials and consistent revenue growth, Sherwin-Williams appears poised for further success in the near future.
